Search Results - "Morinigo, Rosa"

Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery by Ortega, Emilio, Morínigo, Rosa, Flores, Lilliam, Moize, Violeta, Rios, Martin, Lacy, Antonio M., Vidal, Josep

“…Background Bariatric surgery (BS) is widely accepted for the treatment of patients with morbid obesity (MO). We aimed to determine presurgical predictors of…”
Get full text

Long-Term Effects of Roux-en-Y Gastric Bypass Surgery on Plasma Glucagon-Like Peptide-1 and Islet Function in Morbidly Obese Subjects by Vidal, Josep, Nicolau, Joana, Romero, Fabiola, Casamitjana, Roser, Momblan, Dulce, Conget, Ignacio, Morínigo, Rosa, Lacy, Antonio M.

“…Context: An enlarged incretin response after Roux-en-Y gastric bypass (RYGBP) has been proposed to promote excessive β-cell function and mass. Objective: The…”
Get full text

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects by Morínigo, Rosa, Lacy, Antonio M, Casamitjana, Roser, Delgado, Salvadora, Gomis, Ramon, Vidal, Josep

“…It has been proposed, that the dramatic amelioration of type 2 diabetes following Roux-en-Y gastric bypass (RYGBP) could by accounted for, at least in part, by…”
Get full text

Circulating Peptide YY, Weight Loss, and Glucose Homeostasis After Gastric Bypass Surgery in Morbidly Obese Subjects by MORINIGO, Rosa, VIDAL, Josep, LACY, Antonio M, DELGADO, Salvadora, CASAMITJANA, Roser, GOMIS, Ramon

“…To prospectively assess the relationship between circulating peptide YY (PYY), body weight, and glucose tolerance in severely obese subjects undergoing…”
Get full text

Insulin resistance, inflammation, and the metabolic syndrome following roux-en-Y gastric bypass surgery in severely obese subjects by MORINIGO, Rosa, CASAMITJANA, Roser, DELGADO, Salvadora, LACY, Antonio, DEULOFEU, Ramon, CONGET, Ignacio, BARCELO-BATLLORI, Silvia, GOMIS, Ramon, VIDAL, Josep

“…The aim of our study was to evaluate the time course of metabolic syndrome components, insulin sensitivity and inflammatory markers, following laparoscopic…”
Get full text

Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects by Morínigo, Rosa, Moizé, Violeta, Musri, Melina, Lacy, Antonio M., Navarro, Salvador, Marín, José Luís, Delgado, Salvadora, Casamitjana, Roser, Vidal, Josep

“…Context: The mechanisms underlying weight loss after Roux-en-Y gastric bypass (RYGBP) are not well understood. Objective: The objective of the study was to…”
Get full text

Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes by Morínigo, Rosa, Musri, Melina, Vidal, Josep, Casamitjana, Roser, Delgado, Salvadora, Lacy, Antonio M, Ayuso, Carmen, Gomis, Ramon, Corominola, Helena

“…The effects of adiponectin on glucose and lipid metabolism are mediated by the adiponectin receptors, adipoR1 and adipoR2, which are mainly in liver and…”
Get full text

Short-term effects of gastric bypass surgery on circulating ghrelin levels by Morinigo, R, Casamitjana, R, Moize, V, Lacy, A.M, Delgado, S, Gomis, R, Vidal, J

“…Objective: To prospectively evaluate the short‐term effects of Roux‐en‐Y gastric bypass (RYGBP) on ghrelin secretion and its relevance on food intake and body…”
Get full text

The SEEN comprehensive clinical survey of adult obesity: Executive summary by Ballesteros Pomar, María D, Vilarrasa García, Nuria, Rubio Herrera, Miguel Ángel, Barahona, María José, Bueno, Marta, Caixàs, Assumpta, Calañas Continente, Alfonso, Ciudin, Andreea, Cordido, Fernando, de Hollanda, Ana, Diaz, María Jesús, Flores, Lilliam, García Luna, Pedro Pablo, García Pérez-Sevillano, Fernando, Goday, Albert, Lecube, Albert, López Gómez, Juan José, Miñambres, Inka, Morales Gorria, María José, Morinigo, Rosa, Nicolau, Joana, Pellitero, Silvia, Salvador, Javier, Valdés, Sergio, Bretón Lesmes, Irene

Get full text

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving β-cell function at onset of type 1 diabetes mellitus by Recasens, Mònica, Aguilera, Eva, Morı́nigo, Rosa, Casamitjana, Roser, Nicoletti, Ferdinando, Gomis, Ramon, Conget, Ignacio

“…The aim of the study was to examine the effects of intensive insulin therapy using lispro on metabolic control, immunogenicity and β-cell function of newly…”
Get full text

The SEEN comprehensive clinical survey of adult obesity: Executive summary by Ballesteros Pomar, María D., Vilarrasa García, Nuria, Rubio Herrera, Miguel Ángel, Barahona, María José, Bueno, Marta, Caixàs, Assumpta, Calañas Continente, Alfonso, Ciudin, Andreea, Cordido, Fernando, de Hollanda, Ana, Diaz, María Jesús, Flores, Lilliam, García Luna, Pedro Pablo, García Pérez-Sevillano, Fernando, Goday, Albert, Lecube, Albert, López Gómez, Juan José, Miñambres, Inka, Morales Gorria, María José, Morinigo, Rosa, Nicolau, Joana, Pellitero, Silvia, Salvador, Javier, Valdés, Sergio, Bretón Lesmes, Irene

“…Obesity is one of the great challenges in healthcare nowadays with important implications for health so requiring comprehensive management. This document aims…”
Get full text

Diferencias intersexuales de las conductas alimentarias desadaptativas y la evolución de la obesidad en los candidatos de la cirugía bariátrica by Laura Pajares, David Morillo, Joan Seguí, Núria Roca, Javier Foncillas, Rosa Morinigo, Aide De Arriba-Arnau, Luís Fernando Alguacil, Marian Monteverde

Get full text

Response to Decochez et al by AGUILERA, EVA, MORINIGO, ROSA, RECASENS, MONICA, CASAMITJANA, ROSER, CONGET, IGNACIO

Get full text

Glucose Homeostasis Abnormalities in Subjects with Impaired Fasting Glucose by YBARRA, JUAN, COSTA, ANGELS, FERNANDEZ-REAL, JOSE M, MORINIGO, ROSA, CASAMITJANA, ROSER, RICART, WIFRED, GOMIS, RAMON, CONGET, IGNACIO

Get full text

Clinical, metabolic, immunologic and genotypic characteristics in non-pediatric patients with type 1A diabetes mellitus. Onset and short-term prognosis by Aguilera, Eva, Recasens, Mónica, Morínigo, Rosa A, Casamitjana, Roser, Oriola, Josep, Ercilla, Guadalupe, Conget, Ignacio

“…Around 50% of new cases of type 1 diabetes mellitus (DM1) are seen in subjects aged above 15 years. It is of particular interest the characterization of such a…”
Get more information